Predicted effect of direct acting antivirals in the current HIV―HCV-coinfected population in Spain

Direct acting antivirals (DAAs) against HCV are eagerly awaited for HIV-HCV-coinfected individuals. However, the activity of first generation drugs is limited to HCV genotype 1 and is lower in cirrhotics, subtype 1a infections, prior interferon (IFN)-α exposure or unfavourable IL28B alleles. Herein,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antiviral therapy 2012-01, Vol.17 (3), p.571-575
Hauptverfasser:	POVEDA, Eva, VISPO, Eugenia, BARREIRO, Pablo, DE MENDOZA, Carmen, LABARGA, Pablo, VICENTE FERNANDEZ-MONTERO, Jose, MARTIN-CARBONERO, Luz, SORIANO, Vincent
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Antiviral Agents - pharmacology Antiviral Agents - therapeutic use Biological and medical sciences Coinfection - drug therapy Coinfection - virology Female Genotype Hepacivirus - classification Hepacivirus - drug effects Hepacivirus - genetics Hepatitis C, Chronic - complications Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology HIV Infections - complications HIV Infections - drug therapy HIV Infections - virology HIV-1 - drug effects Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Interferons Interleukins - genetics Liver Cirrhosis - drug therapy Liver Cirrhosis - pathology Liver Cirrhosis - virology Male Medical sciences Middle Aged Pharmacology. Drug treatments Predictive Value of Tests Spain Treatment Outcome Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral hepatitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!